Tacropic tacrolimus ointment 0.1% Davipharm treat eczema (10g)

Dosage form Tube x 10g
Specifications Tacrolimus

Ingredient

Composition information	Content
Tacrolimus	0.1%

Uses

Indications

tacropic are indicated for the following cases:

Treatment Organs .

tacrolimus shows that there is a Calcineurin inhibitor and then the main trait of calcium dependence on copying and synthesizing cytokines such as Interleukin (IL-2, IL-3, IL-4, IL-5 and subdivisions such as GM-CSF, TNF-α and IFN-γ) that participate early in the clinical significant activity Know.

Pharmacokinetics

absorption

Most organic eczema patients (adults or children) are treated with single -dose or repeated Tacrolimus ointment (0.03 - 0.3%) with blood levels in blood

Before taking Tacropic tacrolimus ointment 0.1% Davipharm treat eczema (10g)

How to use

Use on the skin.

Wash the sick area, dry and apply a thin layer of medicine.

Dosage

Adults

Apply once or twice daily in damaged skin.

Children from 2 to 15 years old

Using only 0.03%tacrolimus ointment.

Children under 2 years old

Do not recommend using Tacrolimus ointment.

Do not recommend the use of long -term tacrolimus ointment.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

Common, ADR> 1/100

Response on the spot: burning, erythema, pain, irritation, abnormalities, rashes, itching and dermatitis at the position of using the drug.

Infections and parasites: Herpes virus infection (Dermatitis Herpes simplex , folliculitis, herpes simplex [herpes lip], kaposi dump blisters).

Skin and subcutaneous tissue: itching.

Nervous system: Perception and sensory disorders (increased sensation, burning sensation).

Metabolism and nutrition: alcohol intolerance (blushing or skin irritation after alcoholic drinks).

Uncommon, 1/1000

No report.

Rare, ADR

Skin and subcutaneous tissue: acne.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Contraindicated

Contraindications for cases of hypersensitivity to any ingredients of the drug.

Be cautious when used

Patients with eczema organs are susceptible to skin infections. If there is a clinical skin infection, the risk and benefits of the use of Tacrolimus ointment should be considered.

Although the causal relationship has not been established, rare malignant cases include skin malignant and lymphatic conditions that have been reported in patients using Tacrolimus ointment. During the use of Tacrolimus ointment, skin exposure should be limited to natural light or artificial light.

Patients with Nethiton syndrome were reported to have an increase in the concentration of Tacrolimus in the blood after taking Tacrolimus ointment on the spot. It is important to consider the ability to increase the absorption into the body with Tacrolimus after taking Tacrolimus ointment at the patient with Netherton syndrome.

Not evaluated for the safety of Tacrolimus ointment in patients with body redness.

If the signs and symptoms of the eczema are not improved, the next use should be considered.

Not yet established the safety and effectiveness of Tacrolimus ointment used at the place of children under 2 years old.

To be out of reach of children.

The ability to drive and operate machinery

The drug does not affect the ability to drive and operate machinery.

Pregnancy

The use of Tacrolimus ointment has not been studied in pregnant women. Tacrolimus ointment should only be used during pregnancy if the benefits are higher than the risk.

The period of breastfeeding

tacrolimus is excreted on breast milk after using systemic sugar. Should be cautious when using Tacrolimus ointment during breastfeeding.

Interactive drug

Tacrolimus ointment is used on the spot on the skin. Concomitant use with other skin -used preparations, and with unprocessed therapy.

Should avoid simultaneous use of Tacrolimus ointment with treatment therapy with UVA, UVB or in combination with Psoralen (PUVA).

Storage

Store in a dry place, avoid light, temperature not exceeding 300C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.